- Home
- ZYXI vs VXRT Comparison
ZYXI vs VXRT Comparison
Compare ZYXI & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- VXRT
- Stock Information
- Founded
- ZYXI 1996
- VXRT N/A
- Country
- ZYXI United States
- VXRT United States
- Employees
- ZYXI N/A
- VXRT N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZYXI Health Care
- VXRT Health Care
- Exchange
- ZYXI Nasdaq
- VXRT Nasdaq
- Market Cap
- ZYXI 248.4M
- VXRT 200.3M
- IPO Year
- ZYXI N/A
- VXRT N/A
- Fundamental
- Price
- ZYXI $8.11
- VXRT $0.60
- Analyst Decision
- ZYXI Strong Buy
- VXRT Strong Buy
- Analyst Count
- ZYXI 2
- VXRT 2
- Target Price
- ZYXI $14.00
- VXRT $3.00
- AVG Volume (30 Days)
- ZYXI 113.1K
- VXRT 1.6M
- Earning Date
- ZYXI 10-24-2024
- VXRT 11-13-2024
- Dividend Yield
- ZYXI N/A
- VXRT N/A
- EPS Growth
- ZYXI N/A
- VXRT N/A
- EPS
- ZYXI 0.15
- VXRT N/A
- Revenue
- ZYXI $193,665,000.00
- VXRT $16,760,000.00
- Revenue This Year
- ZYXI $10.70
- VXRT $67.95
- Revenue Next Year
- ZYXI $19.78
- VXRT N/A
- P/E Ratio
- ZYXI $54.84
- VXRT N/A
- Revenue Growth
- ZYXI 4.21
- VXRT 303.27
- 52 Week Low
- ZYXI $7.15
- VXRT $0.52
- 52 Week High
- ZYXI $13.77
- VXRT $1.54
- Technical
- Relative Strength Index (RSI)
- ZYXI 47.10
- VXRT 31.25
- Support Level
- ZYXI $7.70
- VXRT $0.67
- Resistance Level
- ZYXI $9.33
- VXRT $0.65
- Average True Range (ATR)
- ZYXI 0.41
- VXRT 0.05
- MACD
- ZYXI -0.11
- VXRT -0.01
- Stochastic Oscillator
- ZYXI 25.15
- VXRT 10.72
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.